StonvexLoading…
StonvexStonvexStonvexCore line items from TDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-28 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $1.56B | $6.12B | $4.50B | $2.96B |
Operating Income | $294.20M | $1.15B | $820.30M | $537.50M |
Net Income | $226.80M | $894.80M | $619.20M | $209.90M |
EPS (Diluted) | $4.85 | $18.88 | $13.06 | $8.41 |
Total Assets | $15.49B | $15.29B | $15.37B | $15.14B |
Total Liabilities | $4.79B | $4.77B | $4.81B | $4.75B |
Cash & Equivalents | $521.40M | $352.40M | $528.60M | $310.90M |
Free Cash Flow OCF − CapEx | $204.30M | $1.07B | $734.80M | $420.90M |
Shares Outstanding | 46.33M | 46.19M | 46.95M | 46.88M |